Table 3 Prevalence and adjusted 1 odds ratios of Impaired fasting glucose by category of body mass index (BMI) after stratification by tertile of serum γ-glutamyltransferase (GGT)
BMI | P trend | P interaction | |||
|---|---|---|---|---|---|
<23 kg/m2 | 23-25 kg/m2 | >25 kg/m2 | |||
Men (n = 2424) | 0.032 | ||||
GGT tertile 1 (0 ~ 22 U/L) | |||||
Case/participants | 95/447 | 45/204 | 44/171 | 0.193 | |
Prevalence | 17.2% | 21.2% | 23.4% | ||
Adjusted OR (95% CI) | reference | 1.2(0.7-2.1) | 1.4(0.8-2.3) | ||
GGT tertile 2 (23 ~ 34 U/L) | |||||
Case/participants | 66/297 | 71/213 | 103/290 | 0.001 | |
Prevalence (%) | 19.8% | 31.4% | 32.4% | ||
Adjusted OR (95% CI) | reference | 1.9(1.2-3.1) | 2.1(1.3-3.3) | ||
GGT tertile 3 (35 ~ 73 U/L) | |||||
Case/participants | 54/233 | 101/238 | 160/331 | <0.001 | |
Prevalence (%) | 20.2% | 42.0% | 49.5% | ||
Adjusted OR (95% CI) | reference | 2.9(1.8-4.8) | 4.0(2.5-6.4) | ||
Women (n = 3652) | 0.059 | ||||
GGT tertile 1 (0 ~ 14 U/L) | |||||
Case/participants | 73/678 | 35/352 | 43/243 | 0.100 | |
Prevalence (%) | 9.8% | 9.5% | 15.8% | ||
Adjusted OR (95% CI) | reference | 0.9(0.6-1.5) | 1.7(1.0-2.8) | ||
GGT tertile 2 (15 ~ 19 U/L) | |||||
Case/participants | 66/491 | 65/262 | 95/348 | <0.001 | |
Prevalence (%) | 13.2% | 24.1% | 26.0% | ||
Adjusted OR (95% CI) | reference | 2.1(1.2-3.5) | 2.2(1.4-3.5) | ||
GGT tertile 3 (20 ~ 48 U/L) | <0.001 | ||||
Case/participants | 72/401 | 94/324 | 215/553 | ||
Prevalence (%) | 16.2% | 29.7% | 37.4% | ||
Adjusted OR (95% CI) | reference | 2.1(1.3-3.2) | 3.1(2.1-4.5) | ||